Phase III randomized trial of sunitinib malate (SU11248) versus interferon-alfa (IFN-{alpha}) as first-line systemic therapy for patients with metastatic renal cell carcinoma (mRCC)
2006
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
135
Citations
NaN
KQI